My take on the $tptx IPO for STAT subscribers. An interesting targeted cancer company. httpswww.statnews.com20190417watchthiscompanyturningpointtherapeuticssharespop45afteripoÂ
My take on the $tptx IPO for STAT subscribers. An interesting targeted cancer company. https://www.statnews.com/2019/04/17/watch-this-company-turning-point-therapeutics-shares-pop-45-after-ipo/ …
17:11 EDT 17 Apr 2019 |
STAT
More From BioPortfolio on "My take on the $tptx IPO for STAT subscribers. An interesting targeted cancer company. https://www.statnews.com/2019/04/17/watch-this-company-turning-point-therapeutics-shares-pop-45-after-ipo/ …"